Modified RSV F proteins and methods of their use

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9675685
APP PUB NO 20140294879A1
SERIAL NO

14221675

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is generally related to modified or mutated respiratory syncytial virus fusion (F) proteins and methods for making and using them, including immunogenic compositions such as vaccines for the treatment and/or prevention of RSV infection.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVAVAX INC700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Liu, Ye Laurel, US 353 2493
Massare, Michael J Mt. Airy, US 27 222
Pushko, Peter Frederick, US 55 897
Smith, Gale Gaithersburg, US 70 738
Wu, Yingyun Gaithersburg, US 17 298
Zhou, Bin Gaithersburg, US 272 904

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 13, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00